Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Recurrence 2 Small Cell Lung Carcinoma 1 Metastatic Castration-Resistant Prostate Cancer 1 Lymphoma, Follicular 1 Adenocarcinoma 1

Interventions

Oxaliplatin 46 Gemcitabine 45 Fluorouracil 40 Capecitabine 31 pembrolizumab 29 Leucovorin 29 Docetaxel 27 Cisplatin 25 Paclitaxel 23 Irinotecan 18 Carboplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 17 Pemetrexed 15 Albumin-Bound Paclitaxel 15 Radiotherapy 14 Nivolumab 12 Ramucirumab 11 Cyclophosphamide 11 Trastuzumab 8 Erlotinib Hydrochloride 8 Taxes 7 Radiosurgery 7 Drug Therapy 7 cemiplimab 6 zolbetuximab 5 trastuzumab deruxtecan 5 regorafenib 5 durvalumab 5 Sorafenib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adenocarcinoma × PF06821497 × Clear all

NCT07592910 2026-05-18

MOMENT

Prostate Cancer Clinical Trials Consortium

Phase 2 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡